MAPLE GROVE, Minn., Oct. 26, 2016 /PRNewswire/ -- Pairnomix, LLC, a new genetic research company, today announced that it will be attending the 45th Child Neurology Society (CNS) annual meeting. Pairnomix offers unique characterization and drug screening services that provide physicians with data on a patient's rare genetic mutation, and on new uses for drugs that could be prescribed today. Representatives from the company will be available to discuss its service offerings at booth #510 at the Vancouver Convention Center, Vancouver BC, October 26-29, 2016.
About Pairnomix
Pairnomix™, a genetic research company, is committed to helping people living with rare diseases understand the genetic cause of their condition and explore potential treatment options that are available today. Pairnomix' initial focus is on advancing personalized research for people living with epilepsy and other disorders of the Central Nervous System. To learn more, please visit www.pairnomix.com.
Logo - http://photos.prnewswire.com/prnh/20151203/292940LOGO
SOURCE Pairnomix, LLC